Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | PTPRC | P08575 | 1/20 | 0.54 |
| ▸ | AR | P10275 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Methoxyanthraquinone SCHEMBL222927 | 0.98 | PTPN1 (0.60) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL23111380 | 0.96 | PTPRC (0.59) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL17439396 | 0.96 | MAPT (0.55) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL2997273 | 0.92 | PTPN1 (0.54) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL10885799 | 0.92 | CA1 (0.53) | PTPN1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL2252533 | 0.92 | CA1 (0.57) | PTPN1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL30629120 | 0.92 | CA1 (0.57) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL8076766 | 0.92 | CA1 (0.57) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL7451901 | 0.92 | CA1 (0.57) | PTPN1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL2993382 | 0.88 | CA1 (0.53) | PTPN1MAPTRAB9AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637600-B2 | Photocurable composition, cured product of same, photofusible resin composition and adhesive set | RESONAC CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-20260132243-A1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RESONAC CORP (JP) | 2026-05-14 | — | — | US | disclosed |
| EP-4410859-B1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTO-MELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RESONAC CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| CN-120153035-A | Resin member, reel body, package, and resin material | 株式会社力森诺科 | 2025-06-13 | — | — | CN | disclosed |
| CN-115698135-B | Photocurable composition, cured product thereof, photo-fusible resin composition, and adhesive kit | 株式会社力森诺科 | 2024-12-17 | — | — | CN | disclosed |
| CN-119096330-A | Method for manufacturing semiconductor device | 株式会社力森诺科 | 2024-12-06 | — | — | CN | disclosed |
| WO-2024204615-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE | 株式会社レゾナック | 2024-10-03 | — | — | WO | disclosed |
| EP-4141079-B1 | PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, PHOTOFUSIBLE RESIN COMPOSITION AND ADHESIVE SET | RESONAC CORP (JP) | 2024-09-25 | — | — | EP | disclosed |
| EP-4410859-A1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTO-MELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | Resonac Corporation (JP) | 2024-08-07 | — | — | EP | disclosed |
| CN-118251448-A | Thermosetting composition, cured product thereof, photo-fusible composition, and method for producing structure | 株式会社力森诺科 | 2024-06-25 | — | — | CN | disclosed |
| EP-1591098-A1 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2005-11-02 | — | — | EP | disclosed |
| US-20040186195-A1 | Photopolymerization initiator and photopolymerizable composition | TOKUYAMA CORPORATION (JP) | 2004-09-23 | — | — | US | disclosed |
| EP-1431315-A2 | Photopolymerization initiator and photopolymerizable composition | Tokuyama Corporation (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-6162824-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ALLELIX NEUROSCIENCE INC. | 2000-12-19 | — | — | US | disclosed |
| US-5736578-A | TREATMENT OF SLEEP DISORDERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-04-07 | — | — | US | disclosed |
| EP-0747345-A2 | Ethylamido fluorenes and improved method of making same | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |
| EP-0531443-A4 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | — | 1993-04-21 | — | — | EP | disclosed |
| EP-0531443-A1 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | NOVA PHARMACEUTICAL CORPORATION (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5079260-A | Side effect reduction; fluorene derivatives | NOVA PHARMACEUTICAL CORPORATION (US) | 1992-01-07 | — | — | US | disclosed |
| WO-1991018596-A1 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | WEITZBERG MOSHE (US) | 1991-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637600-B2 | Photocurable composition, cured product of same, photofusible resin composition and adhesive set | ESD, CDH1, ASH2L | PTPN1 4789/4885MAPT 2260/4885TDP1 2103/4885 |
| US-20260132243-A1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RER1, OXTR, MAP1LC3A | PTPN1 3190/4885MAPT 235/4885TDP1 847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.